The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis
Open accessAbstract
Background and aim: There are limited evidence based data concerning the use of azathioprine in ulcerative colitis. We aimed to compare the efficacy of azathioprine and oral 5-aminosalicylic acid in inducing remission of steroid dependent ulcerative colitis. Methods: Seventy two patients with steroid dependent ulcerative colitis were admitted to this investigator-blind study. Steroid dependence was defined as a requirement for steroid therapy ⩾10 mg/day during the preceding six months, with at least two attempts to discontinue the medication. The disease had to be clinically and endoscopically active at study entry, and all patients were taking systemic prednisolone (40 mg/day). Patients were randomised to receive azathioprine 2 mg/kg/day or oral 5-aminosalicylic acid 3.2 g/day, for a six month follow up period. The outcome of the treatment was defined as (1) success, indicating induction of clinical and endoscopic remission and steroid discontinuation, or (2) failure, indicating the absence of clinical and endoscopic remission and therefore the need for at least one further cycle of systemic steroids to control symptoms, apart from the initial one, or colectomy. Results: Significantly more patients in the azathioprine than in the 5-aminosalicylic acid group had clinical and endoscopic remission, and discontinued steroid therapy, both in the intention to treat (azathioprine v 5-aminosalicylic acid: 19/36 patients (53%) v 7/36 (21%); odds ratio (OR) 4.78 (95% confidence interval (CI) 1.57–14.5)) and per protocol (azathioprine v 5-aminosalicylic acid: 19/33 patients (58%) v 7/34 (21%); OR 5.26 (95% CI 1.59–18.1)) analysis. Conclusions: Azathioprine is significantly more effective than 5-aminosalicylic acid in inducing clinical and endoscopic remission and avoiding steroid requirement in the treatment of steroid dependent ulcerative colitis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
Hanauer, S. B., Feagan, B. G., Lichtenstein, G. R., Mayer, L. F., Schreiber, S., Colombel, J. F., Rachmilewitz, D., Wolf, D. C., Olson, A., Bao, W., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08512-4 · Cited by 4,169
Targan, S. R., Hanauer, S. B., van Deventer, S. J. H., Mayer, L., Present, D. H., Braakman, T., DeWoody, K. L., Schaible, T. F., & Rutgeerts, P. J. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710093371502 · Cited by 3,135
Infliximab for the Treatment of Fistulas in Patients with Crohn's Disease
Present, D. H., Rutgeerts, P., Targan, S., Hanauer, S. B., Mayer, L., van Hogezand, R. A., Podolsky, D. K., Sands, B. E., Braakman, T., DeWoody, K. L., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199905063401804 · Cited by 2,752
Infliximab Maintenance Therapy for Fistulizing Crohn's Disease
Sands, B. E., Anderson, F. H., Bernstein, C. N., Chey, W. Y., Feagan, B. G., Fedorak, R. N., Kamm, M. A., Korzenik, J. R., Lashner, B. A., Onken, J. E., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa030815 · Cited by 2,226
Charbonneau, D. H. (2005) · Europe PMC (PubMed Central) · Cited by 2,041
Cyclosporine in Severe Ulcerative Colitis Refractory to Steroid Therapy
Lichtiger, S., Present, D. H., Kornbluth, A., Gelernt, I., Bauer, J., Galler, G., Michelassi, F., & Hanauer, S. (1994) · New England Journal of Medicine · doi:10.1056/nejm199406303302601 · Cited by 1,714
Faubion, W. A., Loftus, E. V., Harmsen, W. S., Zinsmeister, A. R., & Sandborn, W. J. (2001) · Gastroenterology · doi:10.1053/gast.2001.26279 · Cited by 1,144
The course and prognosis of ulcerative colitis: Part I Short-term prognosis
Edwards, F. C., & Truelove, S. C. (1963) · Gut · doi:10.1136/gut.4.4.299 · Cited by 854
The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review
Fraser, A. G. (2002) · Gut · doi:10.1136/gut.50.4.485 · Cited by 629
Variation Between Observers in Describing Mucosal Appearances in Proctocolitis
Baron, J. H., Connell, A. M., & Lennard-Jones, J. E. (1964) · BMJ · doi:10.1136/bmj.1.5375.89 · Cited by 611
Infliximab for the treatment of fistulas in patients with Crohn's disease
Ricart, E., & Sandborn, W. J. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70414-2 · Cited by 519
Randomised controlled trial of azathioprine withdrawal in ulcerative colitis.
Hawthorne, A. B., Logan, R. F., Hawkey, C. J., Foster, P. N., Axon, A. T., Swarbrick, E. T., Scott, B. B., & Lennard-Jones, J. E. (1992) · BMJ · doi:10.1136/bmj.305.6844.20 · Cited by 452
Van Assche, G., D’haens, G., Noman, M., Vermeire, S., Hiele, M., Asnong, K., Arts, J., D’hoore, A., Penninckx, F., & Rutgeerts, P. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)01214-9 · Cited by 448
Infliximab in the Treatment of Severe, Steroid-Refractory Ulcerative Colitis: A Pilot Study
Sands, B. E., Tremaine, W. J., Sandborn, W. J., Rutgeerts, P. J., Hanauer, S. B., Mayer, L., Targan, S. R., & Podolsky, D. K. (2001) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200105000-00001 · Cited by 422
Farmer, R. G., Easley, K. A., & Rankin, G. B. (1993) · Digestive Diseases and Sciences · doi:10.1007/bf01295733 · Cited by 395
D'Haens, G., Lemmens, L., Nevens, F., Hiele, M., Rutgeerts, P., Vandeputte, L., Peeters, M., Vermeire, S., Geboes, K., Van Acker, F., et al. (2001) · Gastroenterology · doi:10.1053/gast.2001.23983 · Cited by 393
Probert, C. S. J., Hearing, S. D., Schreiber, S., Kühbacher, T., Ghosh, S., Arnott, I. D. R., & Forbes, A. (2003) · Gut · doi:10.1136/gut.52.7.998 · Cited by 355
A Comparison of Oral Prednisolone Given as Single or Multiple Daily Doses for Active Proctocolitis
Powell-Tuck, J., Bown, R. L., & Lennard-Jones, J. E. (1978) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365527809182199 · Cited by 335
Azathioprine in Ulcerative Colitis: Final Report on Controlled Therapeutic Trial
Jewell, D. P., & Truelove, S. C. (1974) · BMJ · doi:10.1136/bmj.4.5945.627 · Cited by 332
Controlled trial of azathioprine in chronic ulcerative colitis.
Kirk, A. P., & Lennard-Jones, J. E. (1982) · BMJ · doi:10.1136/bmj.284.6325.1291 · Cited by 228
The long-term outcome of ulcerative colitis treated with 6-mercaptopurine.
George, J. M., Present, D. H., Pou, R., Bodian, C., & Rubin, P. (1996) · PubMed · Cited by 225
A Controlled Trial of Azathioprine in the Management of Chronic Ulcerative Colitis
Rosenberg, J. L., Wall, A. J., Levin, B., Binder, H. J., & Kirsner, J. B. (1975) · Gastroenterology · doi:10.1016/s0016-5085(19)32641-1 · Cited by 224
Efficacy of anti-tumor necrosis factor therapy in patients with ulcerative colitis
Su, C. (2002) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(02)04384-8 · Cited by 175
The therapeutic efficacy of 6-mercaptopurine in refractory ulcerative colitis.
Adler, D. J., & Korelitz, B. I. (1990) · PubMed · Cited by 172
Alterations of the Immune System in Ulcerative Colitis and Crohn's Disease
Macdermott, R. P., & Stenson, W. F. (1988) · Advances in Immunology · doi:10.1016/s0065-2776(08)60848-2 · Cited by 158
THE TREATMENT OF CHRONIC ULCERATIVE COLITIS WITH 6‐MERCAPTOPURINE
Bean, R. H. D. (1962) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1962.tb20590.x · Cited by 130
Immunoregulation in the gut: success and failures in human disease
Monteleone, I., Vavassori, P., Biancone, L., Monteleone, G., & Pallone, F. (2002) · Gut · doi:10.1136/gut.50.suppl_3.iii60 · Cited by 120
Azathioprine in Steroid-Resistant and Steroid-Dependent Ulcerative Colitis
Ardizzone, S., Molteni, F., Imbesi, V., Bollani, S., & Porro, G. B. (1997) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-199707000-00007 · Cited by 111
Self-citationKohn, A., Prantera, C., Pera, A., Cosintino, R., Sostegni, R., & Daperno, M. (2002) · Digestive and Liver Disease · doi:10.1016/s1590-8658(02)80204-3 · Cited by 85
The role of azathioprine in the management of ulcerative colitis
Lobo, A., Foster, P. N., Burke, D., Johnston, D. A., & Axon, A. T. R. (1990) · Diseases of the Colon & Rectum · doi:10.1007/bf02156261 · Cited by 83
Cited by
Ordás, I., Eckmann, L., Talamini, M., Baumgart, D. C., & Sandborn, W. J. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60150-0 · Cited by 2,078
Kornbluth, A., & Sachar, D. B. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2009.727 · Cited by 2,023
Inflammatory bowel disease: clinical aspects and established and evolving therapies
Baumgart, D. C., & Sandborn, W. J. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60751-x · Cited by 1,920
Peyrin-Biroulet, L., Sandborn, W., Sands, B. E., Reinisch, W., Bemelman, W., Bryant, R. V., D'Haens, G., Dotan, I., Dubinsky, M., Feagan, B., et al. (2015) · American Journal of Gastroenterology · doi:10.1038/ajg.2015.233 · Cited by 1,844
Dignass, A., Lindsay, J. O., Sturm, A., Windsor, A., Colombel, J.-F., Allez, M., D'Haens, G., D'Hoore, A., Mantzaris, G., Novacek, G., et al. (2012) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2012.09.002 · Cited by 1,548
Metadata
- Authors
- Ardizzone, S., Maconi, G., Russo, A., Imbesi, V, Colombo, E., & Bianchi Porro, G.
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2005-06-21
- Volume
- 55
- Issue
- 1
- Pages
- 47-53
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- OpenAlex
- W2115000032
- Cited by
- 505
- References
- 30
- FWCI
- 14.45
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.